A new study has identified a potential strategy for treating multiple forms of cancerous tumors: targeting a protein that maliciously rewires immune cells and impedes cancer therapies. The researchers showed that inhibiting the protein with an existing compound helped slow or even reject tumors stemming from four cancers.
